ISRG vs NVCT · P/E 80, rev $2.89B vs $304.5M cap
Intuitive Surgical Inc (ISRG) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported ISRG revenue for 2026-06-30 was $2.89B. Net income was $818.1M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
NVCT does not have a complete income-statement cache yet.
ISRG currently screens at market cap $195.15B and trailing P/E 80.0. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the ISRG and NVCT stock pages for the full models.
Not investment advice.